Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on [SFHEA]X Ionic Liquid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103497082A reveals a solvent-free Henry reaction using ethanolamine-based ionic liquids, offering high yields and catalyst reusability for reliable pharma intermediate supply chains.